Digital support platform for caregivers of young people with psychosis

Altitudes: A Blended Digital Health Intervention to Support Caregivers and Other Supporters of Young People With Psychosis

Not applicable Interventional University of North Carolina, Chapel Hill · NCT06509100

This study is testing a new online support platform for parents and caregivers of young people with psychosis to see if it helps them feel better and less stressed.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages18 Years to 99 Years
SexAll
SponsorUniversity of North Carolina, Chapel Hill Academic / other
Locations1 site (Chapel Hill, North Carolina)
Trial IDNCT06509100 on ClinicalTrials.gov

What this trial studies

This study investigates the feasibility and potential benefits of a moderated online social media platform called Altitudes, designed to support parents, caregivers, and supporters of young individuals experiencing psychosis. The platform will provide therapeutic and educational content to enhance caregiver wellbeing and reduce stress. Over a period of six months, up to 50 participants from various community services in North Carolina will engage with the platform, and their experiences and psychological status will be evaluated. The study aims to assess the acceptability and usability of the platform through participant feedback and usage metrics.

Who should consider this trial

Good fit: Ideal candidates include parents, caregivers, or supporters of young individuals currently receiving treatment for psychosis in North Carolina.

Not a fit: Patients who are currently engaged in legal action against their loved one may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the mental health and wellbeing of caregivers, reducing their stress and burnout.

How similar studies have performed: While the approach of using digital platforms for caregiver support is emerging, this specific intervention is novel and has not been extensively tested in similar contexts.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The participants must be a parent, caregiver, or supporter of a young person who is currently receiving treatment from a CSC program for FEP or STEP clinic, on the waitlist to receive services from the CSC, who has recently graduated/discharged from a CSC program, or was referred to the study from the community (via Early Psychosis Interventions of North Carolina (EPI-NC) warm line, community psychiatrist/therapist, or inpatient/outpatient mental health services) where young person is experiencing psychosis but was not referred or enrolled in CSC
* Parent, caregiver, or supporter must be \> 18 years of age
* Participants recruited from NC CSC programs (i.e., OASIS, SHORE, Encompass, Eagle, AEGIS, WeCare2), STEP programs, and the community screening process
* Parent, caregiver, or supporter must have access to internet through a mobile phone, tablet, or computer

Exclusion Criteria:

* Parent or caregiver is currently engaged in legal action against the loved one experiencing psychosis
* Parent or caregiver does not speak and understand English as the platform, its moderation, interviews, and measures are available only in English
* Parent, caregiver, or supporter is \<18 years of age

Where this trial is running

Chapel Hill, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Care BurdenCare Giving BurdenCaregiver BurnoutCaregiver StressCaregiver WellbeingSupport, FamilyDigital InterventionSocial Media
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.